SHE:002693 Revenue

Hainan Shuangcheng Pharmaceuticals had revenue of 47.45M CNY in the quarter ending June 30, 2025, a decrease of -8.99%. This brings the company's revenue in the last twelve months to 163.44M, down -14.79% year-over-year. In the year 2024, Hainan Shuangcheng Pharmaceuticals had annual revenue of 174.21M, down -26.16%.

Revenue (ttm)

163.44M

Revenue Growth

-14.79%

P/S Ratio

20.81

Revenue / Employee

270.14K

Employees

605

Market Cap

3.40B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	174.21M	-61.72M	-26.16%
Dec 31, 2023	235.93M	-38.82M	-14.13%
Jan 1, 2023	274.75M	-45.54M	-14.22%
Jan 1, 2022	320.29M	50.85M	18.87%
Dec 31, 2020	269.44M	-77.21M	-22.27%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	30.15B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	41.90B
Sichuan Biokin Pharmaceutical	441.19M
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings